PMA device
TherOx Downstream System
Zoll Circulation, Inc. · System, Oxygen, Aqueous (MWG, Class III) · First FDA decision Apr 2, 2019, newest Apr 10, 2026Heart attack (myocardial infarction)
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
5
Naming "TherOx Downstream"
MAUDE reports
1
Brand "TherOx Downstream", since 2015
PubMed studies
0
Mentioning "TherOx Downstream"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TherOx Downstream System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 9 decisions filed under this name.
- TherOx Downstream SystemPMA supplement
P170027-S018 · Decided Apr 10, 2026 · 395 days after receipt · Normal 180 Day Track No User Fee
Device type: System, oxygen, aqueous (MWG) · Cardiology
5 more FDA decisions with a free account
Older decisions: P170027-S002, P170027-S001, P170027
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TherOx Downstream", any status and sponsor, newest update first.
TherOxNot on our public-company list
NCT04743245 · 17 participants · Start Aug 2, 2022 · Primary completion Apr 10, 2026
Device: TherOx DownStream System; PCI · For: Acute Myocardial Infarction; STEMI
Sites: Springfield, Massachusetts
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TherOx Downstream", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 0 injury, 1 death
Whole product code MWG
15 reports: 2 malfunction, 12 injury, 1 death
Newest reports for this brand
MW5182624 · Received Jan 22, 2026 · Event dated Dec 16, 2025
Device type: System, Oxygen, Aqueous (MWG)
Patient problem as coded: Cardiac Arrest; Ventricular Fibrillation; Obstruction/Occlusion; Thrombosis/Thrombus
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TherOx Downstream"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MWG.
- TherOx® DownStream® Cartridge (DSC-2)Zoll Circulation, Inc. · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.